UPDATE 3-U.S. senators announce bipartisan proposal to lower drug prices

WASHINGTON/NEW YORK, July 23 The top Republican and Democrat on the U.S. Senate Finance Committee announced a proposal to lower prescription drug prices on Tuesday that could save $100 billion in costs to government healthcare programs, and said the committee would vote on the legislation on Thursday.

10:07pm IST

UPDATE 3-Centene signals higher costs in 2019 from Obamacare business

July 23 Centene Corp beat second-quarter sales targets and raised its 2019 earnings forecast on Tuesday, but the health insurer warned of higher medical costs from its Obamacare business this year.

9:04pm IST

UPDATE 3-Multiple sclerosis drug helps Biogen beat Wall St profit expectations

July 23 Biogen Inc reported better-than-expected second quarter profit and raised its 2019 earnings forecast on Tuesday, driven by higher sales of its top-selling multiple sclerosis drug Tecfidera and lower taxes.

8:45pm IST

Biogen profit rises 72%

July 23 Drugmaker Biogen Inc reported a 72.4% rise in second-quarter profit on Tuesday, boosted by higher sales of its multiple sclerosis treatment Tecfidera and lower research and development costs.

4:09pm IST

Centene Corp posts 65% rise in second-quarter profit

July 23 Centene Corp, which is buying smaller rival WellCare Health Plans Inc, on Tuesday reported a 65% rise in quarterly profit, helped by higher sales of its Medicaid health plans for low-income people.

3:37pm IST
BSE OIL & GAS -0.22%
BSE AUTO -0.52%
BSE POWER +1.18%
BSE-CG +0.08%


  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary